MedTrace Logo

Efficacy of MYCOBIOTIC® in Children and Adults With Abdominal Symptoms.

NCT04909437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2023-01-17

No results posted yet for this study

Summary

This is a prospective, randomised, double blind, placebo controlled, parallel arm, cross-over, multicentre study conducted in a population of children and adults with abdominal symptoms observed at outpatient primary health care centres.

Conditions

  • Abdominal Symptoms
  • Stool Culture Positive for Candida Species

Interventions

DIETARY_SUPPLEMENT

Mycobiotic

2 sachet/day, 21 days, oral

DIETARY_SUPPLEMENT

Placebo

2 sachet/day, 21 days, oral

Sponsors & Collaborators

  • Medical Network M. Woynarowski, J. Kierkuś Spółka jawna (MED-NET)

    collaborator UNKNOWN

  • Nature Science Sp. z o.o.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
3 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-19
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04909437 on ClinicalTrials.gov